Thank you Eric, and welcome to everyone. First of all, like Eric said, I would like to review our Q1 results highlights. And in that regard, I am happy to report that our Q1 results were solid as we had predicted. In reviewing our results in detail, you have seen that we've reported healthy revenues, operating margins, and net profit for the quarter. Q1 revenues were recorded at 960 million euros, roughly 50% higher than the same period last year. As indicated during our Q4 earnings call, the average selling price for the quarter was impacted by shipments of i-line tools, as we shipped relatively large volume of XT:400s to newly constructed memory fabs. This is a direct result of market share against for this product line, resulting from our early efforts to significantly increase the value of ownership of these systems. On the operating side, our operating cost grew 26% year-on-year, was mainly driven by increased R&D spend. This resulted in an operating margin in the quarter of 20.5% and that compares to 18.2% the same time last year. However, our first quarter operating results do reflect the impact of the Brion acquisition, which had an impact on our operating income of around 25 million euros; 23 of which was for one-time non-recurring R&D charges. Without the impact of Brion, our operating income would have been 220 million euros or close to 23%. With all these focus on the growth and market share gains, I must note that we have not lost sight of the level of our operational expenditure. Although we have grown our operational cost base to support future growth in both our R&D spend and SG&A cost, we do focus on creating cost variability, such that we can manage the profitability through the cycle. About 30% of the R&D costs are variable in a quarter’s time and approximately 10% of SG&A costs are variable. And that makes ASML pretty flexible and adaptive to any market environment. Although we don’t communicate our unit breakeven level, since we believe that would really only be relevant in extreme business conditions, we do focus on it from an internal point of view. And the internal regular reviews on it are pretty clear and have remained at the breakeven level at a constant low level despite our increase in the absolute operational cost levels. I see unit growth forecasts and also the continued drive of the industry for leading-edge shrink capability. We will keep supporting the lithography equipment growth. I think this was clearly evidenced by good level of order intake in Q1, reaching a level of 911 million euros, leading to another record backlog of close to 2.2 billion euros. Although the order intake was lower in units as compared to previous quarter, the demand for our leading-edge products continues to be high. And it is clearly evidenced by Q1 order average selling price of 15.2 million euros for our new systems. Also in Q1, we continue to execute our share buyback program with the purchase of an additional 8 million shares, which is about 1.3% on outstanding shares. And that actually completed a 10% share buyback as authorized by our shareholders in March of last year. Since we feel confident in our ability to keep generating robust cash flows we have asked for, and we are given the authorization to actually additionally buy back a significant number of ASML shares through September 2008. Net cash from operations was 173 million euros in Q1. That allowed us to end the quarter with cash between 1.4 billion euros and 1.5 billion euros after having used in the first quarter about 350 million euros for the share buyback and the finalization of the Brion acquisition. Now having finalized the Q1 review brings us to the outlook for Q2. With regard to bookings, as we mentioned, by the way, in our previous earnings call, the current market conditions make it difficult to call the exact timing of the order booking. However, we do believe that technology and capacity needs of our customers in the second half will ensure an appropriate level of order intake to justify our growth expectations for the full year. And I would also like to point out that when assessing our quarterly booking levels, it's clear, the focus on unit booking is less relevant now. And it is due to the highly discrepant average selling prices for leading-edge versus trading-edge millimeter systems. And our order book at the end of Q1 is very healthy. And we also expect that our order book, our Q2 backlog levels will remain supportive to our expected 2007 growth scenario. As expected, the Q1 orders from our Flash and DRAM customers decreased in comparison with the last quarter, as these customers have planned a front loaded year. Our logic customers continue the effort to increase capacity in line with what we think is sound IC demand, which resulted in overall in the strong order intake in Q1. And ordering patterns of the different semiconductor market segments, they compensate each other by providing robustness of the total market. Now we can also confirm that our optimism about the year is also based on the industry average IC units forecast by segment as is regularly provided by Gartner Dataquest, VLSI, and iSuppli. And this is currently supporting the custom plans of capacity growth full for litho tools that we currently foresee. As a consequence of this analysis per segment which is confirmed by our Q1 results plus our strong Q1 bookings, our confidence for growth, like I said before, in 2007 is reassured. And is also clearly supported by a record backlog of which 78% is shippable in the next six months and almost all of it before the end of the year. Now, I think that closes my outlook on Q2 and I would like to turn back to you, Eric, for the remaining.